Cigarette Smoke Induces Colorectal Carcinogenesis in Wistar Rats by Decreasing The Expression of APC, MSH2 and MLH1

Dody Novrial(1), Ignatius Riwanto(2), Sutiman Bambang Sumitro(3), Indra Wijaya(4),


(1) Department of Anatomical Pathology, Faculty of Medicine, Jenderal Soedirman University, Indonesia
(2) Department of Digestive Surgery, Faculty of Medicine, Diponegoro University, Indonesia
(3) Department of Cell and Molecular Biology, Brawijaya University, Indonesia
(4) Department of Anatomical Pathology, Faculty of Medicine, Diponegoro University, Indonesia

Abstract

Colorectal carcinogenesis induced by cigarette smoke requires at least 30-40 years. This long time duration causes an animal research conducted becomes relevant. This research was carried out to observe colorectal carcinogenesis due to cigarette smoke exposure in Wistar Rat. The observations focused on changes in epithelial morphology and expression of APC, MSH2 and MLH1. Twenty male Wistar rats inbreed strain were randomly allocated into control group and experimental group exposure to cigarettes smoke for 14 weeks and 28 weeks sequentially.  Colorectal epithelial morphology was assessed on the histopathology examination, whereas the expression of APC, MSH2 and MLH1 was assessed on aspect of immunohistochemistry. The comparative analysis between the two groups was performed using non-parametric Mann-Whitney U test. Histology of colorectal epithelium showed pattern of colitis associated cancer that was significant both in 14 weeks and 28 weeks of treatment.  This research indicated negative expression of APC, MSH2 and MLH1 in the colorectal cancer that were significant at 28 weeks of exposure. This research implies that chronic exposure to cigarette smoke can induce colitis associated colorectal cancer through decreased expression of APC, MSH2 and MLH1. 

Keywords

Cigarette smoke; colitis; colorectal cancer; APC; MSH2; MLH1

Full Text:

PDF

References

Allred, D. C., Harvey, J. M., Berardo, M., & Clark, G. M. (1998). Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol, 11(2), 155-168.

Barbaro, A., De Lerma, Perletti, G., Bonapace, I. M., & Monti, E. (2014). Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer. International Journal of Oncology, 45(3), 959-968.

Carethers, J. M. (2014). Differentiating Lynch-like from Lynch syndrome. Gastroenterology, 146(3), 602-604.

Chen, K., Xia, G., Zhang, C., & Sun, Y. (2015). Correlation between smoking history and molecular pathways in sporadic colorectal cancer: a meta-analysis. International journal of clinical and experimental medicine, 8(3), 3241-3257.

Colgan, S. P., Curtis, V. F., & Campbell, E. L. (2013). The inflammatory tissue microenvironment in IBD. Inflamm Bowel Dis, 19(10), 2238-2244.

Cunningham, J. M., Kim, C. Y., & Christensen, E. R. (2001). The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet, 69(4), 780-790.

Edwards, R. A, Witherspoon, M., & Wang, K. (2009). Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer. Cancer Res, 69(16), 6423-6429.

Ercal, N., Gurer-Orhan, H., & Aykin-Burns, N. (2001). Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Current topics in medicinal chemistry, 1(6), 529-539.

Gay, L. J., Mitrou, P. N., Keen, J., Bowman, R., Naguib, A., Cooke, J., ... & Khaw, K. T. (2012). Dietary, lifestyle and clinicopathological factors associated with APC mutations and promoter methylation in colorectal cancers from the EPIC‐Norfolk study. The Journal of pathology, 228(3), 405-415.

Gillies, R. J., & Gatenby, R. A. (2007). Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer and Metastasis Reviews, 26(2), 311-317.

Giovannucci, E., Colditz, G. A., Stampfer, M. J., Hunter, D., Rosner, B. A., Willett, W. C., & Speizer, F. E. (1994). A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in US women. Journal of the National Cancer Institute, 86(3), 192-199.

Hecht, S. S. (2003). Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nature Reviews Cancer, 3(10), 733-744.

Imtiyaz, H. Z., Williams, E. P., Hickey, M. M., Patel, S. A., Durham, A. C., Yuan, L. J., ... & Simon, M. C. (2010). Hypoxia-inducible factor 2α regulates macrophage function in mouse models of acute and tumor inflammation. The Journal of clinical investigation, 120(8), 2699-2714.

Kasahara, M., Osawa, K., Yoshida, K., Miyaishi, A., Osawa, Y., Inoue, N., ... & Shimada, E. (2008). Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population. Journal of Experimental & Clinical Cancer Research, 27(1), 49.

Laurence, D. R., & Bacharach, A. L. (1964). Evaluation of drug activities: pharmacometrics. London and New York: Academic Press.

Lüchtenborg, M., White, K. K., Wilkens, L., Kolonel, L. N., & Le Marchand, L. (2007). Smoking and colorectal cancer: different effects by type of cigarettes?. Cancer Epidemiology and Prevention Biomarkers, 16(7), 1341-1347.

Marsit, C. J., Christensen, B. C., & Houseman, E. A. (2009). Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis, 30(3), 416-422.

Mutch, M. G., Schoen, R. E., Fleshman, J. W., Rall, C. J., Dry, S., Seligson, D., ... & Hawk, E. (2009). A multicenter study of prevalence and risk factors for aberrant crypt foci. Clinical Gastroenterology and Hepatology, 7(5), 568-574.

Myshkin, A. E., & Khromova, V. S. (2000). Histidin as a mercurial poisoning inhibitor. Biochemical and biophysical research communications, 273(3), 816-819.

Naghibalhossaini, F., Zamani, M., Mokarram, P., Khalili, I., Rasti, M., & Mostafavi-pour, Z. (2012). Epigenetic and genetic analysis of WNT signaling pathway in sporadic colorectal cancer patients from Iran. Molecular biology reports, 39(5), 6171-6178.

Raskov, H., Pommergaard, H. C., Burcharth, J., & Rosenberg, J. (2014). Colorectal carcinogenesis-update and perspectives. World J Gastroenterol, 20(48), 18151-18164.

Slattery, M. L., Curtin, K., Anderson, K., Ma, K. N., Ballard, L., Edwards, S., ... & Samowitz, W. S. (2000). Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. Journal of the National Cancer Institute, 92(22), 1831-1836.

Stepanov, I., Carmella, S. G., Briggs, A., Hertsgaard, L., Lindgren, B., Hatsukami, D., & Hecht, S. S. (2009). Presence of the carcinogen N′-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products. Cancer research, 69(21), 8236-8240.

Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010). Inflammation and colon cancer. Gastroenterology, 138(6), 2101-2114..

Wei, P. L., Lin, S. Y., & Chang, Y. J. (2011). Cigarette smoking and colorectal cancer: from epidemiology to bench. Journal of Experimental & Clinical Medicine, 3(6), 257-261.

Wimmer, K., Kratz, C. P., Vasen, H. F., Caron, O., Colas, C., Entz-Werle, N., ... & Duval, A. (2014). Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘care for CMMRD’(C4CMMRD). Journal of medical genetics, 51(6), 355-365.

Wistuba, I. I., Gazdar, A. F., & Minna, J. D. (2001, April). Molecular genetics of small cell lung carcinoma. In Seminars in oncology (Vol. 28, pp. 3-13). WB Saunders.

Refbacks

  • There are currently no refbacks.




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.